Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (61-70 of 181) with videos related to

Pageof 19
Sort By:
Thyroid : Official Journal of the American Thyroid Association|September 8, 2009
Intratracheal growth of recurrent benign goiterFrederik A Verburg, Martin Gasser, Matthias Beissert, et al.
Biomedicines|March 29, 2023
Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German PopulationFriederike Eilsberger, Michael C Kreissl, Christoph Reiners, et al.
Nuklearmedizin. Nuclear Medicine|June 29, 2016
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4]Markus Dietlein, Wolfgang Eschner, Frank Grünwald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2019
EANM practice guideline for PET/CT imaging in medullary thyroid carcinomaLuca Giovanella, Giorgio Treglia, Ioannis Iakovou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patientsFrederik A Verburg, Michael Lassmann, Uwe Mäder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 14, 2010
EANM procedure guidelines for therapy of benign thyroid diseaseMarcel P M Stokkel, Daria Handkiewicz Junak, Michael Lassmann, et al.
Nuklearmedizin. Nuclear Medicine|December 7, 2016
[Radioiodine therapy for benign thyroid diseases (version 5). German Guideline]Markus Dietlein, Frank Grünwald, Matthias Schmidt, et al.
Biomedicines|May 16, 2023
Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine TumorsDamiano Librizzi, Friederike Eilsberger, Stefan Ottenthaler, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 2020
Reference values for quantitative parameters in renal scintigraphy with Tc-99m-MAG3Friederike Eilsberger, Constantin Reiber, Markus Luster, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 18, 2014
Targeting osteomyelitis with complete [99mTc]besilesomab and fragmented [99mTc]sulesomab antibodies: kinetic evaluationsStefan Gratz, Patrik Reize, Bendix Kemke, et al.
Pageof 19

Showing results (61-70 of 181) with videos related to

Sort By:
Pageof 19
Thyroid : Official Journal of the American Thyroid Association|September 8, 2009
Intratracheal growth of recurrent benign goiterFrederik A Verburg, Martin Gasser, Matthias Beissert, et al.
Biomedicines|March 29, 2023
Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German PopulationFriederike Eilsberger, Michael C Kreissl, Christoph Reiners, et al.
Nuklearmedizin. Nuclear Medicine|June 29, 2016
[Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4]Markus Dietlein, Wolfgang Eschner, Frank Grünwald, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2019
EANM practice guideline for PET/CT imaging in medullary thyroid carcinomaLuca Giovanella, Giorgio Treglia, Ioannis Iakovou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2011
The absorbed dose to the blood is a better predictor of ablation success than the administered 131I activity in thyroid cancer patientsFrederik A Verburg, Michael Lassmann, Uwe Mäder, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 14, 2010
EANM procedure guidelines for therapy of benign thyroid diseaseMarcel P M Stokkel, Daria Handkiewicz Junak, Michael Lassmann, et al.
Nuklearmedizin. Nuclear Medicine|December 7, 2016
[Radioiodine therapy for benign thyroid diseases (version 5). German Guideline]Markus Dietlein, Frank Grünwald, Matthias Schmidt, et al.
Biomedicines|May 16, 2023
Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine TumorsDamiano Librizzi, Friederike Eilsberger, Stefan Ottenthaler, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 2020
Reference values for quantitative parameters in renal scintigraphy with Tc-99m-MAG3Friederike Eilsberger, Constantin Reiber, Markus Luster, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 18, 2014
Targeting osteomyelitis with complete [99mTc]besilesomab and fragmented [99mTc]sulesomab antibodies: kinetic evaluationsStefan Gratz, Patrik Reize, Bendix Kemke, et al.
Pageof 19